Novavax, Inc. (NVAX)
Market: NASD |
Currency: USD
Address: 700 Quince Orchard Road
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Show more
📈 Novavax, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$13.43
-
Upside/Downside from Analyst Target:
113.15%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2019 |
- |
$0.050000 |
- |
2019-05-10 |
- |
Stock split |
|
Total Amount for 2019: $0.050000 |
📅 Earnings & EPS History for Novavax, Inc.
| Date | Reported EPS |
|---|
| 2026-05-06 (estimated upcoming) | - |
| 2026-02-25 (estimated upcoming) | - |
| 2025-11-10 (estimated upcoming) | - |
| 2025-11-09 (estimated upcoming) | - |
| 2025-08-06 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-05-08 | - |
| 2025-05-07 | - |
| 2025-02-27 | -0.83 |
| 2025-02-25 | - |
| 2024-11-12 | -0.76 |
| 2024-08-08 | 0.99 |
| 2024-08-07 | 0.99 |
| 2024-05-10 | -1.05 |
| 2024-05-09 | -1.05 |
| 2024-02-28 | -1.44 |
| 2024-02-27 | -1.44 |
| 2023-11-09 | -1.26 |
| 2023-11-08 | -1.26 |
| 2023-08-08 | 0.58 |
| 2023-08-07 | 0.58 |
| 2023-05-09 | -3.41 |
| 2023-05-08 | -3.41 |
| 2023-02-28 | -2.28 |
| 2023-02-27 | -2.28 |
| 2022-11-08 | -2.15 |
| 2022-11-07 | -2.15 |
| 2022-08-08 | -6.53 |
| 2022-08-07 | -6.53 |
| 2022-05-09 | 2.56 |
| 2022-05-08 | 2.56 |
| 2022-02-28 | -11.18 |
| 2022-02-27 | -11.18 |
| 2021-11-04 | -4.31 |
| 2021-11-03 | -4.31 |
| 2021-08-05 | -4.75 |
| 2021-08-04 | -4.75 |
| 2021-05-10 | -3.05 |
| 2021-05-09 | -3.05 |
| 2021-03-01 | -2.7 |
| 2021-02-28 | -2.7 |
| 2020-11-09 | -3.21 |
| 2020-11-08 | -3.21 |
| 2020-08-10 | -0.3 |
| 2020-08-09 | -0.3 |
| 2020-05-11 | -0.58 |
| 2020-05-10 | -0.58 |
| 2020-03-11 | -1.13 |
| 2020-03-10 | -1.13 |
| 2019-11-06 | -1.11 |
📰 Related News & Research
No related articles found for "novavax inc".
